Arkolith/Insider Trading/ENTA/Form 4

Luly Jay R.

President and CEO, DirectorENANTA PHARMACEUTICALS INC (ENTA) · full profile →Form 4 · filed Feb 13, 2026
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
3
3 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Feb 12, 2026Grant(A)5K—$0863K
Feb 12, 2026Grant(A)15K—$0878K
Feb 12, 2026Tax withholding(F)6K$14.25$88K872K

Transaction Codes

A
Grant / award
F
Shares withheld for taxes

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0002064832-26-000006) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML